Geron (LTS:0IV3) Change In Prepaid Assets : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Geron Change In Prepaid Assets?

Geron's Change In Prepaid Assets for the quarter that ended in Mar. 2024 was $0.00 Mil. It means Geron's Prepaid Assets stayed the same from Dec. 2023 to Mar. 2024 .

Geron's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was $-0.19 Mil. It means Geron's Prepaid Assets declined by $0.19 Mil from Dec. 2022 to Dec. 2023 .

Geron Change In Prepaid Assets Historical Data

The historical data trend for Geron's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Change In Prepaid Assets Chart

Geron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Prepaid Assets

Get a 7-Day Free Trial

-0.84

-1.49

-2.49

-3.22

-0.19

Geron Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Prepaid Assets	Get a 7-Day Free Trial															-	-	-	-	-

Geron Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Geron Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Geron's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Geron (LTS:0IV3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (LTS:0IV3) » Definitions » Change In Prepaid Assets

Comparable Companies

Traded in Other Exchanges

GERN:USA GON:Germany GON:Germany

Address

919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404

Website

https://www.geron.com

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug. the company operates as a single segment, the development of therapeutic products for oncology.

Geron (LTS:0IV3) Headlines

No Headlines